Vanguard Group’s Cellectar Biosciences CLRB Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $401K | Sell |
56,341
-1,665,497
| -97% | -$11.8M | ﹤0.01% | 3972 |
|
2025
Q1 | $542K | Sell |
1,721,838
-5,163
| -0.3% | -$1.63K | ﹤0.01% | 3866 |
|
2024
Q4 | $516K | Buy |
1,727,001
+15
| +0% | +$4 | ﹤0.01% | 3945 |
|
2024
Q3 | $3.7M | Buy |
1,726,986
+163,000
| +10% | +$349K | ﹤0.01% | 3381 |
|
2024
Q2 | $3.91M | Buy |
1,563,986
+372,905
| +31% | +$932K | ﹤0.01% | 3356 |
|
2024
Q1 | $4.74M | Buy |
1,191,081
+708,191
| +147% | +$2.82M | ﹤0.01% | 3318 |
|
2023
Q4 | $1.34M | Buy |
482,890
+307,006
| +175% | +$850K | ﹤0.01% | 3735 |
|
2023
Q3 | $464K | Buy |
175,884
+3,911
| +2% | +$10.3K | ﹤0.01% | 4070 |
|
2023
Q2 | $335K | Sell |
171,973
-3,510
| -2% | -$6.84K | ﹤0.01% | 4217 |
|
2023
Q1 | $251K | Hold |
175,483
| – | – | ﹤0.01% | 4284 |
|
2022
Q4 | $300K | Buy |
175,483
+106
| +0.1% | +$181 | ﹤0.01% | 4223 |
|
2022
Q3 | $589K | Sell |
175,377
-1,578,423
| -90% | -$5.3M | ﹤0.01% | 4169 |
|
2022
Q2 | $708K | Hold |
1,753,800
| – | – | ﹤0.01% | 4193 |
|
2022
Q1 | $1.21M | Sell |
1,753,800
-207,505
| -11% | -$143K | ﹤0.01% | 4151 |
|
2021
Q4 | $1.3M | Sell |
1,961,305
-2,905
| -0.1% | -$1.93K | ﹤0.01% | 4184 |
|
2021
Q3 | $1.82M | Buy |
1,964,210
+89,626
| +5% | +$82.9K | ﹤0.01% | 4090 |
|
2021
Q2 | $2.23M | Buy |
1,874,584
+231,180
| +14% | +$275K | ﹤0.01% | 3941 |
|
2021
Q1 | $2.65M | Buy |
1,643,404
+129,872
| +9% | +$209K | ﹤0.01% | 3800 |
|
2020
Q4 | $3.15M | Buy |
1,513,532
+1,442,695
| +2,037% | +$3M | ﹤0.01% | 3543 |
|
2020
Q3 | $88K | Buy |
70,837
+54,082
| +323% | +$67.2K | ﹤0.01% | 4029 |
|
2020
Q2 | $21K | Hold |
16,755
| – | – | ﹤0.01% | 4060 |
|
2020
Q1 | $22K | Hold |
16,755
| – | – | ﹤0.01% | 4043 |
|
2019
Q4 | $38K | Hold |
16,755
| – | – | ﹤0.01% | 4059 |
|
2019
Q3 | $34K | Hold |
16,755
| – | – | ﹤0.01% | 4104 |
|
2019
Q2 | $37K | Hold |
16,755
| – | – | ﹤0.01% | 4129 |
|
2019
Q1 | $39K | Hold |
16,755
| – | – | ﹤0.01% | 4074 |
|
2018
Q4 | $26K | Hold |
16,755
| – | – | ﹤0.01% | 4108 |
|
2018
Q3 | $50K | Sell |
16,755
-230,247
| -93% | -$687K | ﹤0.01% | 4127 |
|
2018
Q2 | $153K | Buy |
247,002
+2,776
| +1% | +$1.72K | ﹤0.01% | 4008 |
|
2018
Q1 | $277K | Buy |
244,226
+6,800
| +3% | +$7.71K | ﹤0.01% | 3909 |
|
2017
Q4 | $325K | Buy |
237,426
+90,218
| +61% | +$123K | ﹤0.01% | 3841 |
|
2017
Q3 | $246K | Hold |
147,208
| – | – | ﹤0.01% | 3877 |
|
2017
Q2 | $240K | Buy |
147,208
+35,482
| +32% | +$57.8K | ﹤0.01% | 3871 |
|
2017
Q1 | $253K | Buy |
111,726
+41,541
| +59% | +$94.1K | ﹤0.01% | 3867 |
|
2016
Q4 | $85K | Buy |
70,185
+28,952
| +70% | +$35.1K | ﹤0.01% | 3988 |
|
2016
Q3 | $111K | Buy |
41,233
+17,701
| +75% | +$47.7K | ﹤0.01% | 3967 |
|
2016
Q2 | $81K | Buy |
+23,532
| New | +$81K | ﹤0.01% | 4044 |
|